We observed tumor growth and various aspects of factors related to tumor development, including apoptosis, inflammation, and metastasis, to explore the therapeutic properties of zotarolimus and mTOR drugs for lung cancer and thereby increase the number of available drugs for lung cancer treatment choices. The gene discussed is MTOR; the disease is neoplasm.